Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
2020 · New England Journal of Medicine · 6,783 citations
https://doi.org/10.1056/nejmoa1915745
S
Shukui Qin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
573
Papers
51.6K
Citations
76
h-index
234
i10-index
Shukui Qin is an academic researcher from Shanxi Agricultural University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Colorectal Cancer Treatments and Studies & Gastric Cancer Management and Outcomes. The author has an h-index of 76, co-authored 488 publications.
ORCID: 0000-0003-2289-1521Papers by this author
worksLenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
2018 · The Lancet · 5,257 citations
https://doi.org/10.1016/s0140-6736(18)30207-1
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
2016 · The Lancet · 3,590 citations
https://doi.org/10.1016/s0140-6736(16)32453-9
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
2020 · Journal of Clinical Oncology · 1,151 citations
https://doi.org/10.1200/jco.20.01888
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
2020 · The Lancet Oncology · 625 citations
https://doi.org/10.1016/s1470-2045(20)30011-5
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial
2015 · Journal of Clinical Oncology · 614 citations
https://doi.org/10.1200/jco.2015.62.6598
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat